CHE CHEMED CORP NEW revenue, earnings and financials
For the quarter ended June 30, 2026, CHEMED CORP NEW reported revenue of $673M (up 8.8% from a year earlier), net income of $67.7M and diluted EPS of $5.13; over the last four quarters revenue was $2.60B and net income $10.0M; for the fiscal year ended December 2025 revenue was $2.53B, up 4.1% on the year before.
CHE annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $2.53B, gross profit n/a, operating income $338M, net income $265K (margin 0.0%), EPS $18.34
- Fiscal year ended Dec 2024: revenue $2.43B, gross profit n/a, operating income $366M, net income $302K (margin 0.0%), EPS $19.89
- Fiscal year ended Dec 2023: revenue $2.26B, gross profit n/a, operating income $341M, net income $273K (margin 0.0%), EPS $17.93
- Fiscal year ended Dec 2022: revenue $2.13B, gross profit n/a, operating income $343M, net income $250K (margin 0.0%), EPS $16.53
- Fiscal year ended Dec 2021: revenue $2.14B, gross profit n/a, operating income $343M, net income $269K (margin 0.0%), EPS $16.85
CHE quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue $673M (up 8.8% year over year), net income $67.7M, EPS $5.13
- Quarter ended Mar 31, 2026: revenue $658M (up 1.6% year over year), net income $66.3M, EPS $4.84
- Quarter ended Dec 31, 2025 (from the annual report): revenue $639M (down 0.1% year over year), net income −$188M, EPS $5.45
- Quarter ended Sep 30, 2025: revenue $625M (up 3.1% year over year), net income $64.2M, EPS $4.46
- Quarter ended Jun 30, 2025: revenue $619M (up 3.8% year over year), net income $52.5M, EPS $3.57
- Quarter ended Mar 31, 2025: revenue $647M (up 9.8% year over year), net income $71.8M, EPS $4.86
- Quarter ended Dec 31, 2024 (from the annual report): revenue $640M (up 9.2% year over year), net income −$211M, EPS $6.00
- Quarter ended Sep 30, 2024: revenue $606M (up 7.4% year over year), net income $75.8M, EPS $5.00
- Quarter ended Jun 30, 2024: revenue $596M (up 7.6% year over year), net income $70.9M, EPS $4.65
- Quarter ended Mar 31, 2024: revenue $589M (up 5.2% year over year), net income $65.0M, EPS $4.24
- Quarter ended Dec 31, 2023 (from the annual report): revenue $586M (up 7.2% year over year), net income −$182M, EPS $5.91
- Quarter ended Sep 30, 2023: revenue $565M (up 7.2% year over year), net income $75.0M, EPS $4.93
- Quarter ended Jun 30, 2023: revenue $554M (up 4.2% year over year), net income $53.4M, EPS $3.51
- Quarter ended Mar 31, 2023: revenue $560M (up 5.6% year over year), net income $54.1M, EPS $3.58
- Quarter ended Dec 31, 2022 (from the annual report): revenue $547M (up 1.0% year over year), net income −$187M, EPS $4.13
- Quarter ended Sep 30, 2022: revenue $526M (down 2.3% year over year), net income $56.9M, EPS $3.78
- Quarter ended Jun 30, 2022: revenue $531M (down 0.2% year over year), net income $66.5M, EPS $4.40
- Quarter ended Mar 31, 2022: revenue $531M (up 0.6% year over year), net income $64.2M, EPS $4.22
- Quarter ended Dec 31, 2021 (from the annual report): revenue $541M, net income −$194M, EPS $4.78
- Quarter ended Sep 30, 2021: revenue $539M, net income $72.0M, EPS $4.55
CHE cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow $388M, share buybacks $432M
- Fiscal year ended Dec 2024: operating cash flow $417M, share buybacks $361M
- Fiscal year ended Dec 2023: operating cash flow $330M, share buybacks $67.7M
- Fiscal year ended Dec 2022: operating cash flow $310M, share buybacks $115M
- Fiscal year ended Dec 2021: operating cash flow $309M, share buybacks $576M
CHE balance sheet
- Jun 30, 2026: cash $40.2M, total assets $1.58B, total liabilities $749M, shareholders' equity $831M, long-term debt $140M
- Mar 31, 2026: cash $16.9M, total assets $1.54B, total liabilities $688M, shareholders' equity $848M, long-term debt $91.2M
- Dec 31, 2025: cash $74.5M, total assets $1.54B, total liabilities $559M, shareholders' equity $979M
- Sep 30, 2025: cash $130M, total assets $1.62B, total liabilities $547M, shareholders' equity $1.08B
- Jun 30, 2025: cash $250M, total assets $1.72B, total liabilities $519M, shareholders' equity $1.20B
- Mar 31, 2025: cash $174M, total assets $1.73B, total liabilities $545M, shareholders' equity $1.18B
- Dec 31, 2024: cash $178M, total assets $1.67B, total liabilities $550M, shareholders' equity $1.12B
- Sep 30, 2024: cash $238M, total assets $1.77B, total liabilities $534M, shareholders' equity $1.24B
What is CHE's revenue?
CHEMED CORP NEW reported $2.60B of revenue over its last four quarters, through June 30, 2026.
Is CHE profitable?
Yes. CHEMED CORP NEW earned $10.0M over the last four quarters.
What is CHE's EPS?
Diluted earnings per share over the last four quarters were $19.88; $5.13 in the latest quarter.